CVI Holdings’s T2 Biosystems, Inc TTOO Stock Holding History

CVI Holdings’s Portfolio TTOO Stock Details TTOO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-5,495	Closed	-$253K	–	344
2023 Q1	$253K	Buy	+5,495	New	+$600K	0.1%	130

Other funds holding TTOO

GCP

GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Sabby Management Miami Beach, Florida $111M AUM 74.4% 1-Year Est. Return

IWM

IHT Wealth Management Chicago, Illinois $4.7B AUM 25.67% 1-Year Est. Return

CSS

Cubist Systematic Strategies Stamford, Connecticut $21B AUM 21.48% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

BBA

Baader Bank Aktiengesellschaft Unterschleissheim, Germany $1.33B AUM 47.35% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

CVI Holdings's TTOO Position: Q2 2023 in Review

CVI Holdings sold out of T2 Biosystems, Inc (TTOO) in Q2 2023, closing a stake of 5,495 shares — an estimated $253K sold.

CVI Holdings first reported a position in TTOO in Q1 2023 and held it in 1 quarter. The position peaked at $253K in Q1 2023. 28 funds tracked by Wall St. Rank hold TTOO as of Q2 2023.

CVI Holdings reported no remaining T2 Biosystems, Inc position as of Q2 2023 after selling out during the quarter.
CVI Holdings sold 5,495 T2 Biosystems, Inc shares in Q2 2023, an estimated $253K.
CVI Holdings first reported a position in T2 Biosystems, Inc in Q1 2023 and held it in 1 quarter.
CVI Holdings's T2 Biosystems, Inc position peaked at $253K in Q1 2023.
28 funds tracked by Wall St. Rank held T2 Biosystems, Inc as of Q2 2023.

Based on CVI Holdings's 13F filing for Q2 2023, filed 11 Aug 2023.